MYLAN PHARMACEUTICALS INC.

40% of inspections at this establishment produced violations, with 3 inspections producing serious-or-greater violations.

Top OSHA standards cited at this employer, ranked by citation count. Standards (CFR sections) cluster citations into safety themes -- machine guarding, lockout-tagout, hazard communication, fall protection, process safety, etc. A concentration on one or two sections reveals a pattern that individual citations don’t. 20 distinct standards shown · 24 citations in this view · $3,430 in penalties.

Source: OSHA inspection citations (violation_detail). CFR section codes can be looked up at osha.gov/laws-regs for the formal standard text. Per-inspection detail and the specific violation descriptions are available by expanding individual inspections below.

Recordable injury rates the employer filed with OSHA’s Injury Tracking Application. DART covers cases with days away, restricted, or transferred; TRIR is the total recordable case rate.

Reported for 1,645 average annual employees at this establishment.

Source: OSHA ITA Form 300A (employer self-reported). Rates are per 100 full-time equivalent workers. Establishments below the ~10-FTE threshold are not required to report.

Self-reported events under 29 CFR 1904.39 (24-hour notification of hospitalization, amputation, or loss of an eye) · Dec 2015 – Dec 2018

Most frequent event: Caught in running equipment or machinery during maintenance, cleaning

Source: OSHA Severe Injury Reports (federal OSHA only; state-plan states like California, Oregon, and Washington maintain their own programs and do not consistently report into this feed).

Each row is a hospitalization, amputation, or eye-loss event the employer self-reported to OSHA under 29 CFR 1904.39. Narratives are written by the reporting employer.

Source: OSHA Severe Injury Reports. Federal-OSHA jurisdiction only by default; some state-plan programs report voluntarily.

No WHD wage, overtime, or child-labor enforcement cases on file for MYLAN PHARMACEUTICALS INC.. Verify directly with Wage and Hour Division →

No MSHA mine safety violations on file for MYLAN PHARMACEUTICALS INC.. Verify directly with Mine Safety and Health Administration →

Company-level in WV — for Viatris Inc, not this location alone

National Labor Relations Board — unfair labor practice charges and union representation cases. The NLRB records cases at the company/regional level (no worksite address), so these are matched by company name and state and may span other Viatris Inc locations in the same state.

National Labor Relations Board cases involving this employer. Includes unfair labor practice (ULP) filings and representation election proceedings. NLRB enforcement is process-driven; no per-case monetary penalty is assessed (remedies are case-by-case backpay orders, posting requirements, election re-runs, etc.). 8 cases · 8 ULP

Source: NLRB case files. Rows shown are those the agency has published. Region numbers (1–31) correspond to NLRB's geographic offices.

No H-1B, H-2A, or H-2B labor condition applications on file (historical data only — DOL ended OFLC publication) for MYLAN PHARMACEUTICALS INC.. Verify directly with Office of Foreign Labor Certification →

No EPA inspections or formal enforcement actions on file for MYLAN PHARMACEUTICALS INC.. Verify directly with Environmental Protection Agency →

Every EPA ECHO facility associated with this employer, sorted most-significant first. Each row links to EPA’s Detailed Facility Report for the source-of-truth record. Permits column lists active programs (Air = Clean Air Act, Water = Clean Water Act, RCRA = hazardous waste, TRI = Toxics Release Inventory reporting). 1 facility · 1 marked inactive.

Source: EPA ECHO (Enforcement and Compliance History Online). Compliance status follows EPA’s own labels (“Sig Violation” = significant noncompliance; QNCR = quarters of noncompliance over the recent reporting window). Inactive facilities (struck through) retain historical enforcement records even after operations ceased.

Federal Motor Carrier Safety Administration — DOT-regulated carrier registration and fleet data.

No federal criminal prosecutions, plea agreements, or deferred-prosecution agreements on file for MYLAN PHARMACEUTICALS INC.. Verify directly with UVA Corporate Prosecution Registry →

This location

Federal contract dollars to this establishment. Primary NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING. Last action: 2026-03-24. Source: USAspending.gov, net obligations. Recipient address is the SAM registration / HQ address, not necessarily the worksite.